BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33515421)

  • 41. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
    Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
    Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
    Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An inverse interaction between
    Zhang Y; Yuan Y; Li Y; Zhang P; Chen P; Sun S
    Epigenetics; 2019 Oct; 14(10):949-960. PubMed ID: 31144606
    [No Abstract]   [Full Text] [Related]  

  • 44. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway.
    Chen Q; Qin R; Fang Y; Li H
    Cell Physiol Biochem; 2015; 36(3):956-65. PubMed ID: 26087719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
    Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
    Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
    Lee S; Choi EJ; Jin C; Kim DH
    Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
    Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.
    Liu J; Zhang Y; Yu C; Zhang P; Gu S; Wang G; Xiao H; Li S
    Drug Dev Res; 2021 Apr; 82(2):278-286. PubMed ID: 33112006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance.
    Singh M; Chaudhry P; Fabi F; Asselin E
    BMC Cancer; 2013 May; 13():233. PubMed ID: 23663432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms.
    Wu H; Cao Y; Weng D; Xing H; Song X; Zhou J; Xu G; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Nov; 271(2):260-71. PubMed ID: 18657898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL; Yang HJ; Liu B; Liu T
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
    Gagnon V; St-Germain ME; Parent S; Asselin E
    Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway.
    Hou Z; Quan J
    Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.
    Philip CA; Laskov I; Beauchamp MC; Marques M; Amin O; Bitharas J; Kessous R; Kogan L; Baloch T; Gotlieb WH; Yasmeen A
    BMC Cancer; 2017 Sep; 17(1):638. PubMed ID: 28886696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.